Background and Purpose-In Germany, all surgical and endovascular procedures on the carotid bifurcation must be documented in a statutory nationwide quality assurance database. We aimed to analyze the association between procedural and perioperative variables and in-hospital stroke or death rates after carotid endarterectomy. Methods-Between 2009 and 2014, overall 142 074 elective carotid endarterectomy procedures for asymptomatic or symptomatic carotid artery stenosis were documented in the database. The primary outcome of this secondary data analysis was in-hospital stroke or death. Major stroke or death, stroke, and death, each until discharge were secondary outcomes. Adjusted relative risks (RRs) were assessed by multivariable multilevel regression analyses. Results-The primary outcome occurred in 1.8% of patients, with a rate of 1.4% in asymptomatic and 2.5% in symptomatic patients, respectively. In the multivariable analysis, lower risks of stroke or death were independently associated with local anesthesia ( 
ven though information is accumulating, indicating that the risk of stroke associated with medical treatment alone and with carotid endarterectomy (CEA) has fallen significantly over the past 2 decades, 1-5 current guidelines 6-10 still recommend CEA for patients with 60% to 99% asymptomatic or 50% to 99% symptomatic carotid artery stenosis as long as the perioperative stroke and death risk is low. Whereas preceding studies indicated that CEA with patch plasty and eversion CEA have similar complication rates, 11 CEA with primary closure is discouraged. 8, 10 Because the GALA trial (General Anaesthetic Versus Local Anaesthetic for Carotid Surgery) showed no difference in outcomes after CEA based on general or local anesthesia, 12 it is recommended that surgeons and anesthesiologists can make use of either method, depending on local availability and competence. 10 With respect to perioperative measures, antiplatelet medication should be continued. 6, [8] [9] [10] Although widely performed, the impact of any method of neurophysiologic monitoring, [13] [14] [15] or intraoperative completion studies, 16, 17 is the subject of ongoing debates. Because guideline recommendations are exposed to criticism not to reflect the current real-world situation, 1-3 the purpose of this study was to determine factors associated with a reduced in-hospital risk of stroke or death after CEA under routine conditions in Germany.
Stroke
April 2017
performed to treat extracranial carotid artery stenosis. All data are self-reported by the centers providing CEA. Because of legal obligations, the data collection covers nearly all (99.8% in 2014) CEA operations and carotid artery stenting procedures performed in German hospitals registered under §108 SGB V. In 2014, our working group was granted access to the quality assurance data by the G-BA pursuant to §137a Abs. 10 SGB V. This study was approved by the ethics committee of the Technical University of Munich and was performed in accordance with the Good Practice of Secondary Data Analysis 22 and the STROBE Statement. 23 Nonanonymous patient-level data hosted by the AQUA Institute were analyzed by use of so-called controlled remote data processing. Conformance with German data protection laws was controlled by staff members of the AQUA Institute (T.B.).
From January 2009 to December 2014, 163 088 patients who underwent CEA were registered in the German carotid registry. This amounts to 34 CEA procedures in 100 000 inhabitants per year (81 CEA procedures in 100 000 inhabitants per year for population aged ≥50 years). Only patients who were operated electively, defined as not for emergency indications such as crescendo transient ischemic attack or stroke in evolution, were included in the analysis. Furthermore, patients who had surgery under special conditions such as internal carotid artery (ICA) occlusion, restenosis, tandem stenosis, carotid aneurysm, symptomatic ICA coiling, symptomatic low-grade (<50%) stenosis with ulcerated plaque morphology, or simultaneous cardiac or aortic surgery were excluded from the analysis. Please see Figure 1 for inclusion and exclusion criteria.
A total of 142 074 patients were included in this analysis. Among them, 56 336 patients were symptomatic, defined as having experienced neurological symptoms related to the ICA stenosis within the past 180 days. The remaining 85 738 patients were treated for asymptomatic stenosis.
Our primary outcome (dependent variable) was any stroke or death until discharge from hospital. The secondary outcomes were major stroke or death, any stroke, and death, each until discharge.
The neurological outcome was directly coded in a variable as none, transient ischemic attack, or stroke. Grading of neurological deficit was documented in a separate variable according to the modified Rankin scale. Diagnosis of transient ischemic attack (new neurological deficit lasting ≤24 hours) or stroke (new neurological deficit lasting >24 hours) was based on clinical/neurological examination with or without further assessment by computed tomographic imaging or magnetic resonance imaging. Qualification of the physician performing the examination before and after the procedure is coded in 2 separate variables (pre/postprocedural neurological assessment by a specialist in neurology: yes or no, respectively). For the purpose of this study, only strokes (fixed neurological deficits occurring during or after the procedure) were considered as outcome events. 18 To calculate the adjusted relative risk (RR) and 95% confidence intervals (95% CIs) for the independent variables (type of anesthesia, surgical technique, intraoperative completion studies, intraprocedural neurophysiological monitoring, periprocedural antiplatelet therapy, shunt use, and cross-clamp time), a multilevel Poisson regression model [24] [25] [26] [27] was applied. To account for confounding and clustering, the variables age, sex, American Society of Anesthesiologists physical status classification system category, neurological status on admission, ipsilateral and contralateral degree of stenosis, pre-and postprocedural assessment by a specialist in neurology, and the annual hospital volume (empirical quintiles regarding the annual number of CEAs performed: 1-10, 11-26, 27-46, 47-79, and ≥80 CEAs per year) were additionally entered as fixed effect (variables used in the multivariable regression analysis are provided in Table I in the online-only Data Supplement). Anonymized hospital site codes valid in the treatment year were entered into the model as random effect (random intercept only). Because multiple methods for the intraoperative completion studies could have been applied, 2-way interaction terms were additionally added to the model to estimate the independent effect size for each method.
The statistical package R (version 3.2.1; The R Foundation; http://www.r-project.org) was used for data processing and statistical analysis with extension packages gmodels and lme4 to calculate cross-classified tables, χ 2 tests, and multivariable regression analyses. Variable codes were extracted from the codebooks provided by the AQUA Institute and harmonized over the time period from 2009 to 2014.
Results

Baseline Characteristics
On average, the patients were 71 years old, and 68% of all patients were men (Table 1) . Almost 94% had severe (70%-99%) carotid artery stenosis according to the NASCET method (North American Symptomatic Carotid Endarterectomy Trial). Regarding the index events in symptomatic ICA stenosis, most patients had transient ischemic attacks (36%) or minor strokes (26%).
Peri-and Intraoperative Management
A total of 26% of all CEA procedures were performed under locoregional anesthesia (Table 2) . CEA was performed with patch plasty (ie, augmentation of longitudinal arteriotomy by implementation of a patch) in 51% of the patients, whereas eversion CEA (ie, transection of ICA at its origin and eversion of the outer layers of the internal carotid artery over the atherosclerotic plaque) was used in 42%. Primary closure of the arteriotomy (ie, direct suture of longitudinal arteriotomy without using a patch) was used in 1.2%. Other techniques (eg, interposition bypass, transposition of the carotid bifurcation) were used in 5.7%. Intraoperative shunting was conducted in 43% of all CEAs. Intraoperative completion studies were performed in 67% of all patients.
Associations Between Procedural and Perioperative Factors and In-Hospital Risk
Any in-hospital stroke or death rate of the whole cohort was 1.8% (1.4% in asymptomatic patients and 2.5% in symptomatic ASA indicates American Society of Anesthesiologists physical status classification system; ICA, internal carotid artery; n, patients with feature or property; N, all patients with information available; NASCET, North American Symptomatic Carotid Endarterectomy Trial; Q1, first quartile; and Q3, third quartile.
*Information on percentages of subcategories refers to the cohort of symptomatic patients.
†Time from the index event to treatment. ‡Multiple answers possible. ASS indicates acetylsalicylic acid; CEA, carotid endarterectomy; n, patients with feature or property; N, all patients with information available; Q1, first quartile; and Q3, third quartile.
*Patients who received a combination of local and general anesthesia were likely to have predominantly undergone conversion from local to general anesthesia.
†Multiple answers possible. Information on percentages of subcategories refers to the cohort of patients who received intraprocedural neurophysiological monitoring.
‡Other methods include local anesthesia in combination with the duck squeezing test, transcranial Doppler sonography, and measurement of stump pressure.
§Other techniques include interposition bypass and transposition of the carotid bifurcation.
‖As antiplatelet medication was not recorded in 2009, data were available for N=117 973 patients.
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Crude RRs for the associations between technical and perioperative factors and the primary outcome are given in Table 3 .
In the multivariable analysis (Figure 2 ), a significant association with a lower risk of in-hospital stroke or death was observed for local anesthesia versus general anesthesia (RR, 0.85; 95% CI, 0.75-0.95), intraoperative completion study using duplex ultrasound (RR, 0.74; 95% CI, 0.63-0.88) or angiography (RR, 0.80; 95% CI, 0.71-0.90), and perioperative intake of antiplatelet medication (RR, 0.83; 95% CI, 0.71-0.97). Combined/switched anesthesia (RR, 1.57; 95% CI, 1.22-2.01), primary closure of the arteriotomy site (RR, 1.41; 95% CI, 1.03-1.91), usage of an intra-arterial shunt (RR, 1.88; 95% CI, 1.66-2.14), and a prolonged cross-clamp time (RR, 1.11; 95% CI, 1.08-1.15) were associated with higher rates of in-hospital stroke or death. Beyond that, all these associations proved to be statistically significant regarding the occurrence of a major stroke or death. Concerning the occurrence of any stroke until discharge, eversion CEA was significantly associated with a lower risk (RR, 0.85; 95% CI, 0.75-0.97), whereas local anesthesia and perioperative antiplatelet medication were not significantly associated with a lower rate of any in-hospital stroke. With regard to in-hospital death, however, local anesthesia (RR, 0.70; 95% CI, 0.57-0.85) and perioperative antiplatelet medication (RR, 0.73; 95% CI, 0.57-0.94) were associated with lower risks, whereas the operation technique did not show a significant association. See Figures I through III in the online-only Data Supplement for secondary outcome results.
Discussion
Type of Anesthesia
The first main finding of our analysis was that local anesthesia was independently associated with a lower risk of in-hospital stroke or death. The most comprehensive study analyzing the association between type of anesthesia and clinical outcome was a recently updated Cochrane Review on 4596 operations, of which 3526 originated from the GALA trial. 3.6% of all patients allocated for CEA under local anesthesia experienced a perioperative stroke or died compared with 4.2% for patients treated under general anesthesia (OR, 0.85; 95% CI, 0.63-1.16). The authors noted that neither the GALA trial nor the pooled data analysis were adequately powered to detect a statistically significant effect on mortality. 28 Concerning the definition of primary outcomes, the GALA trial and the Cochrane review determined the perioperative period as 30 days from randomization or surgery, respectively. 12, 28 Because in our analysis in-hospital stroke or death was defined as the primary outcome, results are not directly comparable. Because hospital stays vary (Table 1) , the entire rate of primary outcome events within 30 days of surgery might be higher than that recorded in our database. However, after CEA, the majority of events occur within the first days after surgery. 29 Regarding the secondary outcomes, local anesthesia was associated with a lower risk of death, whereas an association with in-hospital stroke could not be shown. The association with a lower mortality is likely to be because of reduced cardiac stress.
A combination of local and general anesthesia showed an increased risk of stroke or death than general anesthesia alone. Although registry data do not provide more detailed information, we think that those patients were likely to have undergone conversion from local to general anesthesia. Because conversion is usually performed if the patient is becoming agitated or if intraoperative problems occur, it is reasonable that these patients had worse outcomes because of selection bias.
Operation Technique
In our analysis, eversion CEA compared with CEA with patch plasty tended to be associated with a lower risk for the occurrence of primary outcome events. This is in accordance with the EVEREST trial (Eversion Carotid Endarterectomy Versus Standard Trial), which was the largest randomized controlled trial comparing the 2 techniques: a logistic regression analysis showed a not significant trend toward a lower incidence of major stroke or death within 30 days after the procedure favoring eversion CEA (hazard ratio, 0.6; 95% CI, 0.5-5.2; P=0.4). 30 Besides differences in the definition of primary outcome events, one other aspect makes a comparison of our results to those of the EVEREST trial difficult. In the latter, eversion CEA was not distinctively compared to CEA with patch plasty but to CEA with patch plasty or primary closure.
CEA with primary closure of the arteriotomy was associated with a higher rate of in-hospital stroke or death in our analysis. This conforms to the findings of the numerically largest meta-analysis comparing the 2 methods, demonstrating a reduction of the perioperative risk of ipsilateral stroke and a nonsignificant trend toward reduction in mortality for patients who underwent CEA with patch plasty.
31
Intraoperative Completion Studies
Our study demonstrates for the first time that the utilization of intraoperative angiography or duplex ultrasound was associated with lower rates of in-hospital stroke or death under real-world conditions in Germany. Besides that, significant associations with lower risks of all secondary outcomes were shown. This finding differs from the results obtained by a retrospective cohort study published by Rockman et al, 17 which with 9278 included CEAs represents the largest study on this topic. In 3318 of the cases, some form of intraoperative imaging was applied. Patients undergoing CEA with intraoperative completion study showed a higher rate of perioperative stroke or death than patients not receiving intraoperative imaging (4.3% versus 3.8%). The difference was not significant. However, the application frequency of different intraoperative imaging methods varied, with angiography and duplex ultrasound being performed only in 178 and 585 cases, respectively. Conceivably, that study was not powered enough for angiography and intraoperative duplex ultrasound. In our investigation, these were the 2 modalities showing the strongest associations with lower rates of perioperative stroke or death. One reason for this finding might be that strokes could be prevented if a completion study leads to intraoperative revision and correction of a defect. Nevertheless, it should not be left unmentioned that completion studies might in general be used more frequently by surgeons who are specialized in carotid surgery and, therefore, might have lower complication rates.
Perioperative Antiplatelet Medication
In the present analysis, antiplatelet medication was associated with a significantly lower rate of any stroke or death, major stroke or death, and death, each until hospital discharge. A trend toward a lower risk of in-hospital stroke was shown. These results, in part, conform to previous studies. The most comprehensive analysis was a review conducted by Engelter and Lyrer 32 on 907 patients, which found perioperative 
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antiplatelet therapy to be significantly associated with a lower rate of perioperative stroke after CEA (OR, 0.58; 95% CI, 0.34-0.98; P=0.04). However, only a trend favoring perioperative antiplatelet medication was detected for reducing mortality. Although the effects are concurrent, differences in primary end point definitions, study designs, and patient populations may explain the difference in effect sizes.
Neurophysiological Monitoring
Application of neurophysiological monitoring showed a trend toward higher rates of in-hospital stroke or death in our analysis. This is in contrast with previous studies indicating a reduced perioperative stroke risk, especially if neuromonitoring is combined with selective shunting. 33, 34 Because the distinct circumstances under which neurophysiological monitoring was used in the database are unknown and many surgeons might apply it when expecting an elevated stroke risk, our results possibly underlie confounding by indication and, therefore, are not comparable with previous studies.
Intra-Arterial Shunting
Our investigation demonstrated that shunt use during CEA was associated with a significantly higher risk of stroke or death. By contrast, a recently updated Cochrane Review, which represents the largest study on this topic, investigated the effect of routine versus selective or no shunting during CEA. The mortality rate within 30 days after surgery tended to be lower in patients who were shunted routinely (OR, 0.45; 95% CI, 0.13-1.59). A trend toward fewer strokes in the shunted group, which similarly did not show statistical significance, was also demonstrated (OR, 0.77; 95% CI, 0.35-1.69). 35 The reason for this discrepancy in the results most likely is confounding by indication. Many centers are likely to follow a regimen of selective shunting, which is generally used if the circle of Willis is incomplete or if the patient develops neurological symptoms intraoperatively. Both scenarios on their own are associated with increased stroke rates and, therefore, reverse causation may be possible. Controlling for these confounders was not possible in our analysis.
Cross-Clamp Time
Prolonged cross-clamp time was associated with an increase of in-hospital stroke or death rate in our study. As the multivariable regression analysis was adjusted for shunt use, our results indicate that a shorter cross-clamp time seems to be associated with lower rates of perioperative stroke or death, irrespective of intraoperative shunting. This may be explained by the fact that prolongation of cross-clamp time might be indicative of a challenging vessel anatomy, surgical problems, or inexperience. Therefore, our result might underlie unobserved confounders. Evidence on the effect of cross-clamp time on the clinical outcome is sparse in the literature. A subgroup analysis of 821 patients included in the International Carotid Stenting Study did not demonstrate an association between prolonged cross-clamp time and perioperative stroke, myocardial infarction, or death. 36 This may be because of differing study settings, patient populations, and sample sizes.
Comparison of Perioperative Stroke and Death Rate With Previous Trials
The overall in-hospital stroke or death rate in our study was 1.8%, with 1.4% and 2.5% for asymptomatic and symptomatic patients, respectively. This differs particularly from previous trials in which patients were randomized up to 35 years (1981-1994) 37 ) patients. However, the perioperative period in these trials was defined to last until 30 days after surgery, whereas the median length of hospital stay in our population was 5 days. Therefore, only the NASCET trial allows a comparison with our study, as it states that 83.7% of perioperative outcome events (perioperative stroke or death at 30 days) occurred within the first 5 days after the operation amounting to a rate of 5.4%.
Recent trials and meta-analyses showed that the perioperative stroke or death rate has decreased during the years and currently is ≈1.2% for asymptomatic 5 and 2.4% in symptomatic 4 patients. Considering these data together with the observed lower ipsilateral annual stroke rate in patients with an asymptomatic carotid stenosis under best medical treatment alone, 2,3 future guidelines should focus on measures to decrease the perioperative stroke risk and to identify patients at an increased stroke risk under nonsurgical treatment.
Limitations
First, because this is an observational study, patients were not randomized for the variables analyzed in this study, and all results are to be construed as associations rather than causal relationships. Even though some variables in this study were significantly associated with better outcomes, any recommendation for clinical practice should be drawn carefully. However, these results describing the real-world practice in Germany comprehensively might be useful for generating hypotheses for future randomized or nonrandomized prospective trials.
Second, follow-up data only covered the in-hospital period and, thus, 30-day results were not available. This selection bias was considered minimal because most perioperative events occur within the first days after CEA. 29 Third, all data are self-reported by the attending physicians, and information bias cannot be ruled out. However, several approaches to assure correct documentation are implemented (validation rules during data entry, inconsistency indicators, and random sample data validation). Nonetheless, underreporting of adverse events cannot be excluded completely and might have resulted in the low perioperative stroke or death rates of 1.4% in asymptomatic patients and 2.5% in symptomatic ones. In contrast to our data, a meta-analysis from 2003 resulted in perioperative stroke or death rates of 2.8% and 5.1%, respectively. 40 However, perioperative stroke or death rates have been decreasing during the years. 4, 5 Despite the fact that under-reporting of adverse events cannot be excluded completely, this information bias was considered homogeneous among the variables analyzed in this study.
Fourth, because indications for intraoperative shunt use were not available, we were not able to analyze the associations between routine, selective, or no shunting on the perioperative outcome.
Fifth, the database does not provide information on specific comorbidities, cardiovascular risk profile, routine medication, timing of antiplatelet medication, intraoperative heparin or protamine application, and reasons for the application of a certain operational technique or adjunct measure. Therefore, residual confounding might be possible. Equally, no information is supplied on whether intraoperative completion studies caused an operative revision or not. No information is provided about the cause of death.
However, by identification of these drawbacks, this study might help improving the quality assurance program with respect to the validity of future analyses.
Summary
In conclusion, our investigation is one of the largest studies to analyze the association between technical factors and adjunct measures and the risk of stroke or death in the perioperative period after CEA. Despite the known limitations of an observational study, data collection for this study was prospective, nationwide, and unselected. Because participation in the registry was compulsory, the present data set is almost complete and represents the real-world practice in Germany from 2009 to 2014. Factors that were identified to be associated with lower stroke or death rates were local anesthesia, patch plasty compared with primary closure, intraoperative completion study by means of duplex ultrasound or angiography, and perioperative antiplatelet medication. These factors are supposed to help achieving the lowest possible risk after CEA in routine practice and, in the opinion of the authors, should be encouraged. No shunting and a short cross-clamp time were also associated with a lower in-hospital stroke or death rate. Both factors, however, are suspected to be confounded.
